{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"oculocutaneous-albinism-type-4","columns":[{"gene":"","key":"population-6024c6df59064b019f33","label":"Albinism, oculocutaneous, type IV","mondoId":"MONDO:0011683","onsetQualifier":null,"originColumnKey":"MONDO:0011683/OMIM:606574","originalViews":[{"key":"MONDO:0011683/OMIM:606574","label":"Albinism, oculocutaneous, type IV","scopeLabel":"OMIM:606574","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["057609776affec42801d262a0a9557a80fd8eabeb734f90764f677e02191a656","137590f736c72647393f75babc93a4e98de5b51ab7678e68942be93bddb4e8ab","77e4feb35aec43cc96c3be483fd17212a37992569f975d092bb084fdbe69bdfd","8104544aa98f6f514673fe9e79512b9cb22c254a74857cda2595edd133d5840a","aa099aedec3d8100e535a1b9cbabf1c35864128fc746907d4bef81a3649eae95","f3f638ecb136d383768ade15c08fc82f5a8856cb6de659b851a5289282caba7e","fcaf3fd3ff7d20768c01c1c801a0d95b17f655ebe3d752f6b92a85ef2a9935d9"],"recordQualifiers":{},"scopeLabel":"OMIM:606574","sourceIds":["OMIM:606574"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-e0f4bca11166a746fae2","label":"Oculocutaneous albinism type 4","mondoId":"MONDO:0011683","onsetQualifier":null,"originColumnKey":"MONDO:0011683/ORPHA:79435","originalViews":[{"key":"MONDO:0011683/ORPHA:79435","label":"Oculocutaneous albinism type 4","scopeLabel":"ORPHA:79435","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["04b68aff559bce547423fe078c674e087a5ac91359f12af34f6fc0d03ded2adc","0a3dd3adfd1444c1688aa5d3f989954dfc4d29d1d8c9aff7fccdada1d9f97461","1ac6e160ee05c612821535923cb9ee9e79839a89abb18f7fa4a3d4ab0984ee0a","2d55d43c350114c0a276c3166be51b6095495ed31a0a7884e678b1a59db8467d","31efd420b157785384a0173e74f65d52e1ac3bcf68083bfaad4f6aa68efd0542","3ef0713448b5d7e34f5a17568b74e8df250b61fbebc8b2b8aaea1bbbc2d87a9d","4d7510875b7ddc3e5a166e8b7184fd962052dba8168eacc4ad3c8435908279bc","5add63401c861570fafdbeede63f9969975229c145761f89b2fc7a5e75252e3a","61a69f82906cbe875c7cb129db199c12ba51b36939e26c961776dcff02e9f9b5","6210a725bd23254fb22dea3b05f7cfca7d80e8ab3de23e83f27f74a395dd7597","68a9201fc18cf01b8ef0d72b2cf09d0fa220dda5c890766492cf76b78217463b","c3b49e749e65645829946a6fe93f66d66d4bf0671d09f21a393f73fb4c1caabe","cddad2c0c65787875887a804fd295b198bebb5ef5c205bc0ac55d7d501b6c286","d70d5eeccce6fa63bb57d1d6fb30ec2191817147e59dce125108bc98cc3c310f","e0c3d24e60e030cead12c44accaa6d54305d707f55fa10e40f44bbde2254899a"],"recordQualifiers":{},"scopeLabel":"ORPHA:79435","sourceIds":["ORPHA:79435"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6024c6df59064b019f33","population-e0f4bca11166a746fae2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007703","HP:0001022","HP:0000635","HP:0007894","HP:0005599","HP:0001010","HP:0007750"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"orphanet":15,"published":7}},"features":[{"hpoId":"HP:0007703","label":"Abnormal retinal pigmentation","primary":true},{"hpoId":"HP:0001022","label":"Albinism","primary":true},{"hpoId":"HP:0000635","label":"Blue irides","primary":true},{"hpoId":"HP:0007894","label":"Fundus hypopigmentation","primary":true},{"hpoId":"HP:0005599","label":"Hypopigmentation of hair","primary":true},{"hpoId":"HP:0001010","label":"Hypopigmentation of the skin","primary":true},{"hpoId":"HP:0007750","label":"Hypoplasia of the fovea","primary":true},{"hpoId":"HP:0007730","label":"Iris hypopigmentation","primary":false},{"hpoId":"HP:0001104","label":"Macular hypoplasia","primary":false},{"hpoId":"HP:0008069","label":"Neoplasm of the skin","primary":false},{"hpoId":"HP:0003764","label":"Nevus","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0001107","label":"Ocular albinism","primary":false},{"hpoId":"HP:0025551","label":"Optic nerve misrouting","primary":false},{"hpoId":"HP:0000613","label":"Photophobia","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0001072","label":"Thickened skin","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false},{"hpoId":"HP:0011364","label":"White hair","primary":false}],"ledeHtml":"Oculocutaneous albinism type 4 (OCA4) is characterized by: (1) the ocular changes found in all types of albinism that include nystagmus; reduced iris pigment with iris translucency; reduced retinal pigment with visualization of the choroidal blood vessels on ophthalmoscopic examination; foveal hypoplasia associated with reduction in visual acuity that depends on the amount of iris and retinal pigment; and misrouting of the optic nerves at the chiasm associated with alternating strabismus, reduced stereoscopic vision, and altered visual evoked potential; and (2) reduced pigmentation of the skin and hair that ranges from minimal to near normal. Infants with OCA4 are usually recognized by age one year due to hypopigmentation of the skin and hair that ranges in color from silvery white to light yellow. Although hair color may darken with time, it does not vary significantly from childhood to adulthood.","mondoId":"MONDO:0011683","node":{"canonicalSlug":"oculocutaneous-albinism-type-4","comparisons":[{"documentSha256":"d972cabe5ad0c2b0cbe4f932912eacf3e7f938d0af4d4a80f5b1830550bb96a2","key":"legacy-oculocutaneous-albinism","kind":"legacy","label":"oculocutaneous albinism","memberIds":["MONDO:0008746","MONDO:0008747","MONDO:0011683","MONDO:0014070","MONDO:0014127","MONDO:0018135","MONDO:0018264","MONDO:0018910","MONDO:0030899"],"mondoId":"MONDO:0018910","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/oculocutaneous-albinism.d972cabe5ad0c2b0cbe4f932912eacf3e7f938d0af4d4a80f5b1830550bb96a2.json"},{"documentSha256":"5896cda54519b93cb09466b74f84c1a44ee288559b6a6a128b0a68d84eac7104","key":"expanded-oculocutaneous-albinism","kind":"expanded","label":"oculocutaneous albinism","memberIds":["MONDO:0008745","MONDO:0008746","MONDO:0008747","MONDO:0011683","MONDO:0011749","MONDO:0014070","MONDO:0014127","MONDO:0018135","MONDO:0018136","MONDO:0018137","MONDO:0018264","MONDO:0018910","MONDO:0030899","MONDO:0040654"],"mondoId":"MONDO:0018910","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-5896cda54519b93cb094.5896cda54519b93cb09466b74f84c1a44ee288559b6a6a128b0a68d84eac7104.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"Oculocutaneous Albinism Type 4","paragraphs":["Oculocutaneous albinism type 4 (OCA4) is characterized by: (1) the ocular changes found in all types of albinism that include nystagmus; reduced iris pigment with iris translucency; reduced retinal pigment with visualization of the choroidal blood vessels on ophthalmoscopic examination; foveal hypoplasia associated with reduction in visual acuity that depends on the amount of iris and retinal pigment; and misrouting of the optic nerves at the chiasm associated with alternating strabismus, reduced stereoscopic vision, and altered visual evoked potential; and (2) reduced pigmentation of the skin and hair that ranges from minimal to near normal. Infants with OCA4 are usually recognized by age one year due to hypopigmentation of the skin and hair that ranges in color from silvery white to light yellow. Although hair color may darken with time, it does not vary significantly from childhood to adulthood."],"reviewed":"2026-02-12","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:04:36.286523+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK1510/"},"ownColumnKeys":["population-6024c6df59064b019f33","population-e0f4bca11166a746fae2"],"publication":"published","relationships":[{"kind":"parent","label":"oculocutaneous albinism","mondoId":"MONDO:0018910","slug":"oculocutaneous-albinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/16722","pageMondoId":"MONDO:0011683","source":"GARD","name":"Oculocutaneous albinism type 4","url":"https://rarediseases.info.nih.gov/diseases/16722","relationToPage":"same-condition","coveredMondoIds":["MONDO:0011683"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:42:04Z","upstream":"PlainLanguagePilotV2-Jan24","rawAttribution":"MONDO:0011683","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"range","key":"04b68aff559bce547423fe078c674e087a5ac91359f12af34f6fc0d03ded2adc","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001010","is_excluded":false,"label":"Hypopigmentation of the skin","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"057609776affec42801d262a0a9557a80fd8eabeb734f90764f677e02191a656","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":"9/18","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"PMID:14961451","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0a3dd3adfd1444c1688aa5d3f989954dfc4d29d1d8c9aff7fccdada1d9f97461","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"137590f736c72647393f75babc93a4e98de5b51ab7678e68942be93bddb4e8ab","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007894","is_excluded":false,"label":"Fundus hypopigmentation","onset_id":null,"reference":"PMID:11574907","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1ac6e160ee05c612821535923cb9ee9e79839a89abb18f7fa4a3d4ab0984ee0a","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001072","is_excluded":false,"label":"Thickened skin","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2d55d43c350114c0a276c3166be51b6095495ed31a0a7884e678b1a59db8467d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025551","is_excluded":false,"label":"Optic nerve misrouting","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31efd420b157785384a0173e74f65d52e1ac3bcf68083bfaad4f6aa68efd0542","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005599","is_excluded":false,"label":"Hypopigmentation of hair","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3ef0713448b5d7e34f5a17568b74e8df250b61fbebc8b2b8aaea1bbbc2d87a9d","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011364","is_excluded":false,"label":"White hair","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d7510875b7ddc3e5a166e8b7184fd962052dba8168eacc4ad3c8435908279bc","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001022","is_excluded":false,"label":"Albinism","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5add63401c861570fafdbeede63f9969975229c145761f89b2fc7a5e75252e3a","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0003764","is_excluded":false,"label":"Nevus","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61a69f82906cbe875c7cb129db199c12ba51b36939e26c961776dcff02e9f9b5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007703","is_excluded":false,"label":"Abnormal retinal pigmentation","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6210a725bd23254fb22dea3b05f7cfca7d80e8ab3de23e83f27f74a395dd7597","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000613","is_excluded":false,"label":"Photophobia","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"68a9201fc18cf01b8ef0d72b2cf09d0fa220dda5c890766492cf76b78217463b","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0008069","is_excluded":false,"label":"Neoplasm of the skin","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"77e4feb35aec43cc96c3be483fd17212a37992569f975d092bb084fdbe69bdfd","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"PMID:14722913","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8104544aa98f6f514673fe9e79512b9cb22c254a74857cda2595edd133d5840a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001104","is_excluded":false,"label":"Macular hypoplasia","onset_id":null,"reference":"PMID:14722913","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"aa099aedec3d8100e535a1b9cbabf1c35864128fc746907d4bef81a3649eae95","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001022","is_excluded":false,"label":"Albinism","onset_id":null,"reference":"PMID:14961451","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c3b49e749e65645829946a6fe93f66d66d4bf0671d09f21a393f73fb4c1caabe","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cddad2c0c65787875887a804fd295b198bebb5ef5c205bc0ac55d7d501b6c286","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001107","is_excluded":false,"label":"Ocular albinism","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d70d5eeccce6fa63bb57d1d6fb30ec2191817147e59dce125108bc98cc3c310f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007730","is_excluded":false,"label":"Iris hypopigmentation","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0c3d24e60e030cead12c44accaa6d54305d707f55fa10e40f44bbde2254899a","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79435","disease_name":"Oculocutaneous albinism type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:79435","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f3f638ecb136d383768ade15c08fc82f5a8856cb6de659b851a5289282caba7e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0005599","is_excluded":false,"label":"Hypopigmentation of hair","onset_id":null,"reference":"PMID:11574907","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fcaf3fd3ff7d20768c01c1c801a0d95b17f655ebe3d752f6b92a85ef2a9935d9","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606574","disease_name":"Albinism, oculocutaneous, type IV","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000635","is_excluded":false,"label":"Blue irides","onset_id":null,"reference":"PMID:14961451","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1510/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16722\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011683\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-title</dd><dt>Upstream attribution</dt><dd>GeneReviews clinical characteristics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Oculocutaneous albinism type 4 (OCA4) is characterized by: (1) the ocular changes found in all types of albinism that include nystagmus; reduced iris pigment with iris translucency; reduced retinal pigment with visualization of the choroidal blood vessels on ophthalmoscopic examination; foveal hypoplasia associated with reduction in visual acuity that depends on the amount of iris and retinal pigment; and misrouting of the optic nerves at the chiasm associated with alternating strabismus, reduced stereoscopic vision, and altered visual evoked potential; and (2) reduced pigmentation of the skin and hair that ranges from minimal to near normal. Infants with OCA4 are usually recognized by age one year due to hypopigmentation of the skin and hair that ranges in color from silvery white to light yellow. Although hair color may darken with time, it does not vary significantly from childhood to adulthood.</p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1510/\" rel=\"noreferrer\">GeneReviews</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"oculocutaneous-albinism-type-4","sourceDocuments":[{"name":"GeneReviews: Oculocutaneous Albinism Type 4","reviewed":"2026-02-12","source_release":"2026-10-18 12:04:36.286523+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK1510/"},{"name":"GARD: Oculocutaneous albinism type 4","reviewed":null,"source_release":"2026-10-25T03:42:04Z","url":"https://rarediseases.info.nih.gov/diseases/16722"},{"name":"MONDO: oculocutaneous albinism type 4","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011683"}],"sourceNote":"","synonyms":["albinism, oculocutaneous, type IV","OCA4","oculocutaneous albinism caused by mutation in SLC45A2","SLC45A2 oculocutaneous albinism"],"takeawayHtml":"","title":"oculocutaneous albinism type 4"},"schemaVersion":1}
